Intravenous Iron Injection in Cancer Patients With Anemia
NCT04187716 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 341
Last updated 2020-01-22
Summary
* Multifactorial pathogenesis is involved in anemia of cancer patients and defining the causes of anemia is not always simple.
* Currently, treatment options available for anemia in cancer patients include red blood cell (RBC) transfusion, erythropoietin stimulating agent (ESA), and iron supplementation, accompanying considerable pros and cons for each treatment.
* Previous studies have demonstrated benefit when treating with IV iron in combination with ESA and, more recently, evidence is emerging to suggest a role for IV iron alone.
* In this study, investigator will assess the efficacy of intravenous iron for the treatment of anemia in cancer patients.
* Improvement of anemia and the improvement of quality of life compared to conservative treatment of intravenous iron
Conditions
- Cancer Anaemia
Interventions
- DRUG
-
Ferinject
For patients undergoing chemotherapy, ferinject 1000mg will be injected within 24 hours or 24 hours after day 1 of the next chemotherapy cycle. Patients using targeted therapies can be dosed at any time after recognizing Hb 8.0-10.5g / dL and injecting 1000 mg of ferinject.
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
JunHo Jang, ph.D · Samsung Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2020-12-01
- Completion
- 2020-12-01
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical Patients
NCT03565354 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
NCT01043172 ·Status: COMPLETED ·Phase: PHASE2
-
Non-OpeRative MANagement of Rectal Cancer Patients
NCT04696757 ·Status: COMPLETED ·Phase: PHASE2
-
Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC
NCT03156036 ·Status: COMPLETED ·Phase: PHASE2
-
Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer
NCT06047015 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Acute Myocardial Infarction in Cancer Patients
NCT06281054 ·Status: ACTIVE_NOT_RECRUITING
-
Concurrent Chemo-proton Radiotherapy With or Without Resection and Spacer Insertion for Loco-regional Recurrence of Previous Irradiated Rectal Cancer
NCT03098108 ·Status: UNKNOWN ·Phase: NA
-
A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.
NCT01929421 ·Status: COMPLETED ·Phase: PHASE2
-
Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
NCT00506623 ·Status: UNKNOWN ·Phase: PHASE2
-
Multicenter Cross Sectional Study of Primary Intestine Lymphoma
NCT01043302 ·Status: COMPLETED
-
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
NCT03008499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer
NCT07257523 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer
NCT01186081 ·Status: COMPLETED ·Phase: PHASE3
-
Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
NCT01781403 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.
NCT02277158 ·Status: UNKNOWN ·Phase: PHASE1
-
UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer
NCT05148767 ·Status: RECRUITING ·Phase: PHASE4
-
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
NCT06621173 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer
NCT00654342 ·Status: UNKNOWN ·Phase: NA
-
Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy
NCT01435200 ·Status: COMPLETED ·Phase: PHASE3
-
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
NCT03659448 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2
NCT03556345 ·Status: COMPLETED ·Phase: PHASE2
-
Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer
NCT03577665 ·Status: RECRUITING ·Phase: NA
-
Intraoperative Radiation Therapy for Resectable Pancreatic Cancer
NCT03273374 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
NCT05338866 ·Status: ENROLLING_BY_INVITATION
-
Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea
NCT05587387 ·Status: UNKNOWN